Ingredients of organ dysfunction or failure

World Journal of Surgery

Volumn 20, Issue 4, 1996, Pages 430-436

  Gullo, A ^a   Berlot, G ^a  

^a University Medical School   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PANCREATITIS; ADULT RESPIRATORY DISTRESS SYNDROME; HUMAN; INFECTION; INFLAMMATION; INTENSIVE CARE UNIT; INTESTINE PERFUSION; MEDIATOR RELEASE; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; RETROPERITONEAL HEMORRHAGE; REVIEW; RISK FACTOR; SEPSIS;

BACTERIAL TRANSLOCATION; CAPILLARY PERMEABILITY; ENDOTOXINS; HUMANS; INFLAMMATION MEDIATORS; INTESTINAL ABSORPTION; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; RISK FACTORS; SURVIVAL RATE;

EID: 0029981734     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900068     Document Type: Review

References (97)

1. Trunkey, D.D.: Initial treatment of patients with severe trauma. N. Engl. J. Med. 324:1259, 1991
2. Deitch, E.A.: Multiple organ failure: pathophysiology and potential failure therapy. Ann. Surg. 216:117, 1992
3. Heard, S.O., Fink, M.P.: Multiple organ failure syndrome. Part 1. Epidemiology, prognosis and pathophysiology. J. Intens. Care Med. 6:27, 1991
4. Marik, P.E.: Gastric intramucosal pH: a better predictor of MODS and death than oxygen derived variables in patients with sepsis. Chest 104:225, 1993
5. Knaus, W.A., Draper, E.A., Wagner, D.P.O., Zimmerman, J.E.: Prognosis in acute organ system failure. Ann. Surg. 202.685, 1985
6. Tilney, N.L, Bailey, G.L., Morgan, A.P.: Sequential system failure after rupture of abdominal aortic aneurysm. Ann Surg. 178:117, 1973
7. Baue, A.E.: Multiple, progressive, sequential system failure: a syndrome of the 1970s. Arch. Surg. 110:779, 1975
8. Mythen, M.G., Webb, A.R.: Intraoperative gut mucosal hypoperfusion is associated with increased postoperative complications and costs. Intens. Care Med. 2:99, 1994
9. Doglio, G., Pusajo, J., Egurrola, M., et al.: Gastric mucosal pH as a prognostic index of mortality in critically ill patients. Crit. Care Med. 19:1037, 1991
10. Callery, M.P., Kamei, T., Mangino, M.J., Flye, W.: Organ interactions in sepsis. Arch. Surg. 126:28, 1991
11. Molloy, R.G., Mannick, J.A., Rodrick, M.L.. Cytokines, sepsis and immunomodulation. Br. J. Surg. 80:289, 1993
12. Rees, C.: Cytokines as biological response modifiers. J. Clin. Pathol. 45:93, 1992
13. Parillo, J.E., Parker, M.M., Natanson, C., Suffredini, A.F., Danner, R.L., Ognibene, P.P.: Septic shock in humans. Ann. Intern. Med. 113:221, 1990
14. Birkenmaier, C., Hong, Y.S., Horn, J.K.: Modulation of the endotoxin receptor CD in septic patients. J. Trauma 32:473, 1992
15. Suffredini, A.F., Fromm, R.E., Parker, M.M., et al.: The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321:280, 1989
16. Michie, H.R., Manogue, K.R., Springs, D.R., et al.: Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 23:1481, 1988
17. Christman, J.W., Wheeler, A.P., Bernard, G.R.: Cytokines and sepsis: what are the therapeutic implications? J. Crit. Care 6:172, 1991
18. Billiar, T.R.: No: novel biology with clinical relevance. Ann. Surg. 221:339, 1995
19. Danner, R.L., Elin, R.J., Hosseini, J.M., et al. Endotoxemia in human septic shock. Chest 99:169, 1991
20. Rush, B.F., Sori, A.J., Murphy, T.F., et al.: Endotoxemia and bacteremia during hemorrhagic shock: the link between trauma and sepsis? Ann. Surg. 207:549, 1988
21. Marano, M.A., Fong, Y., Moldawer, L.L., et al.: Serum cachectin/ tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg. Gynecol. Obstet. 170:32, 1990
22. Hoch, R.C , Rodriguez, R., Manning T., et al. Effects of accidental trauma on cytokine and endotoxin production. Crit. Care Med. 21:869, 1993
23. Fukushima, R., Alexander, J.W., Gianotti, L., Ogke, C.K.: Isolated pulmonary infections act as a source of systemic tumor necrosis factor. Crit. Care Med. 22:114, 1994
24. Shenep, J., Flynn, P.M., Barrett, F.F., et al.: Serial quantitation of endotoxemia and bacteremia during therapy for gram - bacterial sepsis. J. Infect. Dis. 157:565, 1988
25. Ghezzi, P., Dinarello, C., Bianchi, M., Rosandich, M.E., Repine, J.E., White, C.W.: Hypoxia increases production of interleukin 1 and tumor necrosis factor by human mononuclear cells. Cytokine 3:189, 1991
26. Levine, B., Kaiman, J., Mayer, L., Fillit, H.M., Packer, M.: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323.326, 1990
27. Dinarello, C.A.: The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of septic shock syndrome. J. Infect. Dis. 163:1177, 1991
28. Chaplin, D.D., Hogquist, K A.: Interaction between TNF and interleukin-1. In Tumor Necrosis Factor, B. Beutler, editor. New York, Raven Press, 1992, pp. 197-220
29. Gaynor, E.R., Vitek, L., Sticklin, L., et al.: The hemodynamic effects of treatment with interleukin-2 and lymphokine activated killer cells. Ann. Intern. Med. 109:953, 1988
30. Mela, L., Bacalzo, L.V., Miller, L.D.: Defective oxidative metabolism of rat mitochondria in hemorrhagic and endotoxic shock. Am. J. Physiol. 22:571, 1971
31. Kopprasch, S., Horkner, R., Orlik, H.: Energy state, glycolytic intermediates and mitochondrial function in liver during reversible and irreversible endotoxic shock. Biomed. Biochim. Acta 48:653, 1989
32. 31P-RMN spectroscopy. Am. J. Physiol. 257:C1055, 1989
33. Pasque, M.K., Murphy, C.E., van Tright, P.: Myocardial adenosine triphosphate levels during early sepsis. Arch. Surg. 118: 1437, 1983
34. Grace, P.A.: Ischemia-reperfusion injury. Br. J. Surg. 81:637, 1994
35. McCord, J.M.: Oxygen-derived free radicals, in post-ischemic tissue injury. N. Engl. J. Med. 312:159, 1985
36. Lowell, J.A , Schifferdecker, C., Driscoll, D.F., Benotti, P.N., Bistrian, B.R.: Postoperative fluid overload: not a benign problem. Crit. Care Med. 18:728, 1990
37. Cotran, R.S.: Cytokine and endothelial cell biology. Physiol. Rev. 70.427, 1990
38. Niederman, M.S.: Gram - colonization of the respiratory tract: pathogenesis and clinical consequences. Semin. Respir. Infect. 5:173, 1990
39. Fink, M.P.: Gastrointestinal mucosal injury in experimental models of shock, trauma and sepsis. Crit. Care Med. 19:627, 1991
40. Jacobson, L.F., Noer, R.F.: The vascular pattern of the intestinal villi in various laboratory animals and in man. Anat. Rev. 114:85, 1952
41. Jodal, M., Lundgren, M.: Plasma skimming in the intestinal tract. Acta Physiol. Scand. 80:50, 1970
42. Porter, J.M., Sussman, M.S., Bulkley, G.B.: Splanchnic vasoconstriction in circulatory shock. In Splanchnic Ischemia and Multi-organ Failure. A Marston, G.B. Bulkley, R.G. Fiddian-Green, et al., editors. London, Edward Arnold, 1989, pp. 73-88
43. Jones, W.G., II, Minei, J.P., Barber, A.E., et al.: Bacterial translocation and intestinal atrophy after thermal injury and burn wound sepsis. Ann. Surg. 211:399, 1990
44. Lang, C.H., Bagby, G.J., Ferguson, J.L., et al.: Cardiac output and redistribution of organ blood flow in hyperrnetabolic sepsis. Am. J. Physiol. 246:R331, 1984
45. Aulick, L.H., Goodwin, C.W., Becker, R.A., et al.: Visceral blood flow following injury. Ann. Surg. 93:112, 1981
46. Dahn, M.S., Lange, P., Lobdel, K., et al.: Splanchnic and total body oxygen consumption differences in septic and injured patients. Surgery 100:69, 1987
47. Ruokonen, E., Takala, J., Kari, A., Saxen, H., Mertsola, J., Hansen, E.J.: Regional blood flow and oxygen transport in septic shock. Crit. Care Med. 21:1296, 1993
48. Ruokonen, E., Takala, J., Kari, A.: Regional blood flow and oxygen transport in patients with low cardiac output syndrome after cardiac surgery. Crit. Care Med. 21:1304, 1993
49. Usaro, A., Ruokonen, E., Takala, J.: Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br. J. Anaesth. 74:149, 1995
50. Gonzalez-Crussi, F., Hsueh, W.: Experimental models of ischemic bowel necrosis: the role of platelet activating factor and endotoxin. Am J. Pathol. 112:127, 1983
51. Madara, J.L., Stafford, J.: Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83:724, 1989
52. Wilmore, D.W., Smith, R.J., O'Dwyer, S.T., et al.: The gut: a central organ after surgical stress. Surgery 104:917, 1989
53. Mainous, M.R., Deitch, E.A.: Bacterial translocation and its potential role in the pathogenesis of multiple organ failure. J. Intens. Care Med. 7:101, 1992
54. Wells, F.C., Newsom, S.W.B., Rowlands, C.: Wound infection in cardiothoracic surgery. Lancet 1:1209, 1983
55. Ziegler, E.J., McCuchan, J.A., Fierer, J., et al.: Treatment of grambacteremia and shock with human antiserum to a mutant Escherichia coli. N. Engl. J. Med. 307:1225, 1982
56. Lachman, E., Pitsoe, S.B., Gaffin, S.L.. Antilipopolysaccharide immunotherapy in the management of septic shock of obstetrical and gynecological origin. Lancet 1:981, 1984
57. Fomsgaard, A., Back, L., Foomsgard, J.S., et al.: Preliminary study in treatment of septic shock patients with antilipopolysaccharide IgG from blood donors. Scand. J. Infect. Dis. 21:697, 1988
58. Talan, D.A. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers. Ann. Emerg. Med. 22:1871, 1993
59. Greenman, R.L., Schein, R.M.H., Martin, M.A., et al.: A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram - sepsis. J.A.M.A. 206.1097, 1991
60. Cunnion, R.E.: Clinical trials of immunotherapy for sepsis. Crit. Care Med. 20:721, 1992
61. Ziegler, E.J., McCutchan, J.A., Fierer, J , et al.: Treatment of gram - bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: a randomized, double-blind, placebo controlled trial. N. Engl. J. Med. 324:429, 1991
62. Fisher, C.J., Zimmerman, J., Khazaeli, M.B., et al.: Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndrome. Crit. Care Med. 18:1311, 1990
63. Greenberg, R.N., Wilson, K.M., Kunz, A.Y., Wedel, N.I., Gorelick, K.J.: Observations using anti-endotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious gram - sepsis. Crit. Care Med. 20:730, 1992
64. McCloskey, R.V., Straube, R.C., Sanders, C., et al.: Tre atment of septic shock with human monoclonal antibody HA-1A. Ann. Intern. Med. 12:1, 1994
65. Mannion, B.A., Weiss, J. Esbach, P.: Separation of sublethal and lethal effects of bactericidal/permeability increasing protein on Escherichia coli. J. Clin. Invest. 86:641, 1990
66. Rogy, M.A., Moldawer, L.L., Oldenburg, H.S.A., et al.: Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI. Ann. Surg. 220:7, 1994
67. Manthous, C.A., Hall, J.B., Samsel, R.W.: Endotoxin in human disease. Part 2. Biological effects and clinical evaluations of antiendoloxin therapies. Chest 104:1872, 1993
68. Quezado, Z.M.N., Hoffman, W.D., Banks, S., et al.: Therapeutic trial of reconstituted human high density lipoprotein in a dog model of gram - septic shock. Clin. Res. 41:175A, 1993
69. Hughes, B., Madan, P.R., Paratt, J.R.: Polymyxin B sulphage protects cats against the hemodynamic and metabolic effects of E. Coli endotoxin. Br. J. Pharmacol. 74:101, 1981
70. Kodama, M., Tani, T., Aoki, H., Hanasawa, H., Yoshioka, T.: Treatment of sepsis with extracorporeal elimination of endotoxin [abstract]. Circ. Shock 34:115, 1991
71. Bysani, G.K., Shenep, J.L, Hildner, W.K., Stidham, G.L., Roberson, P.K.: Detoxification of plasma containing lipopolysaccharide by adsorption. Crit. Care Med. 18:67, 1990
72. Vincent, J.L., Bakker, J., Marecaux, G., et al.: Administration of anti-TNF antibodies improves left ventricular function in septic shock patients: results of a pilot study. Chest 101:810, 1992
73. Fisher, C.J., Opam, S.M., Dhainhaut, J.F., et al.: Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit. Care Med. 3:318, 1993
74. Fisher, E., Marana, M.A., Van Zee, K.J., et al.: Interleukin-1 receptor antagonist improves survival an hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J. Clin. Invest. 89:1551, 1992
75. Opal, S.M.: IL-1ra as a therapeutic modality in sepsis. In Yearbook of Intensive Care and Emergency Medicine, J.L. Vincent, editor. New York, Springer-Verlag, 1993, pp. 106-113
76. Dhainaut, J.F., Tenaillon, A., Le Tulzo, Y., et al.: Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter study. Crit. Care Med. 22.1720, 1994
77. Bone, R.C.: Phospholipids and their inhibitors: a critical evaluation of their role in the treatment of sepsis. Crit. Care Med. 20:884, 1992
78. Berlot, G., Barzilay, E., Gullo, A.: Extracorporeal supportive techniques in the treatment of multiple organ failure. Minn. Med. 80:1309, 1989
79. Barzilay, E., Kessler, D., Lesmes, C., Lev, A., Weselr, N., Berlot, G : Sequential plasma filter dialysis with slow, continuous hemofiltration: additional treatment for sepsis induced AOSF treatment. J. Crit. Care 3:163, 1988
80. Storck, M., Hartl, W.H., Zimmerer, E., Inthorn, D.: Comparison of pump-driven and spontaneous continuous hemofiltration in postoperative acute renal failure. Lancet 337:452, 1991
81. Barzilay, E., Kessler, D., Berlot, G., Gullo, A., Geber, D., Ben Zeev, I.: The use of extracorporeal supportive techniques as additional treatment for sepsis-induced MOF patients. Crit. Care Med. 17:634, 1989
82. Bellomo, R., Tipping, P., Boyce, N.: Continuous venovenous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Grit. Care Med. 21:522, 1993
83. Byrick, R.J., Goldstein, M.B., Wong, P.J.: Increased plasma tumor necrosis factor concentration in severe rhabdomyolysis is not reduced by continuous arteriovenous hemodialysis. Crit. Care Med. 20:1483, 1992
84. Gutierrez, G., Clark, C., Brown, S., Price, K., Ortiz, L., Nelson, C.: Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am. J. Respir. Crit. Care 150:324, 1994
85. Smithies, M.N., Yee, T.H., Jackson, L., Bihari, D.J.: Improving splanchnic perfusion: the effects of dopexaraine. Intens. Care Med. 18:P445, 1992
86. Rademacher, P., Buhl, R., Kemnitz, J., et al.: Prostacyclin improves gastric intramucosal pH in patients with septic shock. Clin. Intens. Care 4(Suppl.):9, 1993
87. Gutierrez, G.: Cellular energy metabolism during hypoxia. Crit. Care Med. 19:619, 1991
88. Paraviainen, I., Ruokonen, E., Takala, J.: Dobutamine-induced dissociation between changes in splachnic blood flow and gastric intramucosal pH after cardiac surgery. Br. J. Anesth. 74:227, 1995
89. Silverman, H.J., Tuma, P.: Gastric tonometry in patients with sepsis: effects of dobutamine infusions and packed red blood cell transfusions. J.A.M.A. 269:3024, 1993
90. Fox, A.D., Kripke, S.A., Berman, J.R., et al.: Reduction of the severity of enterocolitis by glutamine-supplemented enteral diets. Surg. Forum 35:43, 1987
91. Guedon, G., Schmidtz, J., Loerbours, E., et al.: Decreased brush border hydrolase activities without gross morphological changes in human intestinal mucosa after prolonged total parenteral nutrition of aduits. Gastroenterology 90:373, 1986
92. Cerra, F.B., McPherson, J.P., Konstantinides, F.P., Konstantinides, N.N., Teasley, K.M.: Enteral nutrition does not prevent multiple organ failure syndrome (MOFS) after sepsis. Surgery 104:722, 1988
93. Alexander, J.W., Gottschlich, M.M.: Nutritional immunomodulation in burn patients. J. Crit. Care Med. 18:S149, 1990
94. Daly, J.M., Lieberman, M.D., Goldfine, J., et al.: Enteral nutrition with supplemented arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic and clinical outcome. Surgery 112:56, 1992
95. Stoutenbeek, C.P., van Saene, H.K.F.: Prevention of pneumonia by selective decontamination of the digestive tract (SDD). Intens. Care Med. 18:S18, 1992
96. Martinez-Pellus, A.E., Merino, P., Bru, M., et al.: Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit. Care Med. 21: 1684, 1994
97. Bion, J.F., Badger, I., Crosby, H.A., et al.: Selective decontamination of the digestive tract reduces gram - pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit. Care Med. 22:40, 1994